The British pharmaceutical giant has joined the direct-to-consumer push, following Pfizer and Amgen’s announcements in ...
A new version of the controversial bill removes the specific company names that were included in a previous iteration but ...
Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they "continue to look for more" from ...
GoodRx, an online platform that offers drug discount coupons to patients, is in talks with the government to participate in ...
The British proposal to increase support for pharma is “clearly positive,” according to analysts at Leerink, who noted that ...
Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the ...
The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been ...
Privately-held Ferring Pharmaceuticals will part ways with up to 500 employees across its global operations in a bid to ...
Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.
New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.
Sanofi’s Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints, which included a measure ...
In the Phase III FIBRONEER-IPF study, Jascayd demonstrated significant lung capacity improvements over placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback